Expertise in
5
conditions

Dr. Joel R. Rosh

Pediatric Gastroenterology | Pediatrics
100 Madison Avenue, 
Morristown, NJ 
 (1917.7 mi)
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
100 Madison Avenue, 
Morristown, NJ 
 (1917.7 mi)
OverviewInsuranceLocationsClinical Research

Overview

Joel Rosh is a Pediatric Gastroenterologist and a Pediatrics provider in Morristown, New Jersey. Dr. Rosh is highly rated in 5 conditions, according to our data. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Colitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 105 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Gastroenterology
Pediatrics
Licenses
Pediatric Gastroenterology in NJ
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Humana

Locations

100 Madison Avenue, Morristown, NJ 07960

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Recruiting
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous As Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous As Maintenance Therapy in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Active_not_recruiting
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases (IBD) Including Drug Levels: a Multi-center Prospective Cohort Study, From the Pediatric IBD Porto Group of European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Enrollment Status: Completed
Publish Date: October 25, 2022
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Not Applicable
View 4 Less Clinical Trials

105 Total Publications

Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease.
Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease.
Journal: Gastroenterology
Published: July 15, 2024
Similar Doctors
Expertise in
9
conditions
Dr. Mirna J. Chehade
Pediatric Gastroenterology | Pediatrics
Expertise in
9
conditions
Dr. Mirna J. Chehade
Pediatric Gastroenterology | Pediatrics
1 Gustave L Levy Pl, Box 1200, 
New York, NY 
 (26.9 mi)
212-241-9464
Languages Spoken:
English

Mirna Chehade is a Pediatric Gastroenterologist and a Pediatrics provider in New York, New York. Dr. Chehade is highly rated in 9 conditions, according to our data. Her top areas of expertise are Eosinophilic Esophagitis, Esophagitis, Gastritis, Viral Gastroenteritis, and Endoscopy.

Expertise in
1
conditions
Dr. Nader N. Youssef
Pediatric Gastroenterology
Expertise in
1
conditions
Dr. Nader N. Youssef
Pediatric Gastroenterology
100 Madison Ave, 
Morristown, NJ 
 (0.1 mi)
973-971-5595
Languages Spoken:
English, Arabic
Accepting New Patients

Nader Youssef is a Pediatric Gastroenterologist in Morristown, New Jersey. Dr. Youssef is highly rated in 1 condition, according to our data. His top area of expertise is Short Bowel Syndrome. Dr. Youssef is currently accepting new patients.

Expertise in
6
conditions
Dr. Neal S. Leleiko
Pediatric Gastroenterology | Pediatrics
Expertise in
6
conditions
Dr. Neal S. Leleiko
Pediatric Gastroenterology | Pediatrics
3959 Broadway Fl 7, 
New York, NY 
 (27.5 mi)
212-305-5903
Languages Spoken:
English
See accepted insurances

Neal Leleiko is a Pediatric Gastroenterologist and a Pediatrics provider in New York, New York. Dr. Leleiko is highly rated in 6 conditions, according to our data. His top areas of expertise are Viral Gastroenteritis, Hemorrhagic Proctocolitis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile